All results For patients For health professionals Medical encyclopedia News & articles Internet results

Drug images Click to enlarge

Targacept?s TC-5214 Achieves All Primary and Secondary Outcome Measures in Phase 2b Trial as Augmentation Treatment for Major Depressive Disorder
...daily for the first four weeks and 40mg daily for the next four weeks. Citalopram, an approved treatment for MDD marketed in the United States as Celexa®, is from the drug class known as selective serotonin reuptake inhibitors. At the end of the eight weeks, subjects whose Montgomery-Asberg Depression...
Clinical Trial Results (FDA) · More like this

Teens with Treatment-resistant Depression More Likely to Get Better with Switch to Combination Therapy
...The teens were randomly assigned to one of four interventions for 12 weeks: -- Switch to another SSRI -- paroxetine (Paxil), citalopram (Celexa) or fluoxetine (Prozac) -- Switch to a different SSRI plus cognitive behavioral therapy (CBT), a type of psychotherapy that emphasizes problem-solving...
Clinical Trial Results (FDA) · More like this

FDA Proposes New Warnings About Suicidal Thinking, Behavior in Young Adults Who Take Antidepressant Medications
...Guides to FDA for review. Products involved in today's action include: Anafranil (clomipramine) Asendin (amoxapine) Aventyl (nortriptyline) Celexa (citalopram hydrobromide) Cymbalta (duloxetine) Desyrel (trazodone HCl) Elavil (amitriptyline) Effexor (venlafaxine HCl) Emsam (selegiline) Etrafon...
News & Articles (Drugs.com) · More like this

Targacept's TC-5214 Achieves All Primary and Secondary Outcome Measures in Phase 2b Trial as Augmentation Treatment for Major Depressive Disorder
...daily for the first four weeks and 40mg daily for the next four weeks. Citalopram, an approved treatment for MDD marketed in the United States as Celexa®, is from the drug class known as selective serotonin reuptake inhibitors. At the end of the eight weeks, subjects whose Montgomery-Asberg Depression...
Clinical Trial Results (FDA) · More like this

Targacept Presents Data from Highly Successful Phase 2b Trial of TC-5214 as Augmentation Treatment for Major Depressive Disorder
...daily for the first four weeks and 40mg daily for the next four weeks. Citalopram, an approved treatment for MDD marketed in the United States as Celexa®, is from the drug class known as selective serotonin reuptake inhibitors. At the end of the eight weeks, subjects whose MADRS score had improved...
Clinical Trial Results (FDA) · More like this

See also: Anxiety and Stress, Depression, Generalized Anxiety Disorder, Obsessive Compulsive Disorder, Panic Disorder, Postpartum Depression, Premenstrual Dysphoric Disorder, Vulvodynia

Having trouble finding what you want?

• Try browsing our A-Z List of Drug Names or our Medical Encyclopedia.
• Try posting your query on the Drugs.com Community Discussion Boards
• Drug Interactions Checker provides detailed information on drug-drug and drug-food interactions.
• Pill Identifier will help you identify an unknown pill by imprint code or shape/color.
• Image Search is helpful if you want to know what a certain pill looks like.
• News, FDA Approvals or In The Pipeline may help if the drug you are looking for is a new drug.